Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arda Durmaz

Showing results (1-10 of 53) with videos related to

Pageof 6
Sort By:
Elife|March 1, 2024
Capturing the unpredictability of stem cellsArda Durmaz, Valeria Visconte
Evolutionary Bioinformatics Online|October 6, 2022
Stability of scRNA-Seq Analysis Workflows is Susceptible to Preprocessing and is Mitigated by Regularized or Supervised ApproachesArda Durmaz, Jacob G Scott
Pacific Symposium on Biocomputing. Pacific Symposium on Biocomputing|March 10, 2021
Frequent Subgraph Mining of Functional Interaction Patterns Across Multiple CancersArda Durmaz, Tim A D Henderson, Gurkan Bebek
Pacific Symposium on Biocomputing. Pacific Symposium on Biocomputing|November 30, 2016
FREQUENT SUBGRAPH MINING OF PERSONALIZED SIGNALING PATHWAY NETWORKS GROUPS PATIENTS WITH FREQUENTLY DYSREGULATED DISEASE PATHWAYS AND PREDICTS PROGNOSISArda Durmaz, Tim A D Henderson, Douglas Brubaker, et al.
International Journal of Molecular Sciences|March 10, 2022
Personalized Risk Schemes and Machine Learning to Empower Genomic Prognostication Models in Myelodysplastic SyndromesHussein Awada, Carmelo Gurnari, Arda Durmaz, et al.
British Journal of Haematology|January 31, 2023
Are the current guidelines for identification of myelodysplastic syndrome with germline predisposition strong enough?Oriol Calvete, Julia Mestre, Arda Durmaz, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|April 16, 2026
YIA26-001: Collateral Sensitivities Emerge During the Evolution of Chemoresistance to Map Chemotherapy in OsteosarcomaZachary Burke, Gabe Mandel, Elizabeth Nowak, et al.
Blood Cells, Molecules & Diseases|February 26, 2021
Friend or foe? The case of Wilms' Tumor 1 (WT1) mutations in acute myeloid leukemiaHassan Awada, Arda Durmaz, Carmelo Gurnari, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|March 31, 2026
YIA26-001: Collateral Sensitivities Emerge During the Evolution of Chemoresistance to Map Chemotherapy in OsteosarcomaZachary Burke, Gabe Mandel, Elizabeth Nowak, et al.
NPJ Genomic Medicine|April 28, 2026
Pleiotropic germline PTEN mutations influence gastrulation through dysregulated AKT activationOmer Enes Onur, Juan Andres Venegas, Arda Durmaz, et al.
Pageof 6

Showing results (1-10 of 53) with videos related to

Sort By:
Pageof 6
Elife|March 1, 2024
Capturing the unpredictability of stem cellsArda Durmaz, Valeria Visconte
Evolutionary Bioinformatics Online|October 6, 2022
Stability of scRNA-Seq Analysis Workflows is Susceptible to Preprocessing and is Mitigated by Regularized or Supervised ApproachesArda Durmaz, Jacob G Scott
Pacific Symposium on Biocomputing. Pacific Symposium on Biocomputing|March 10, 2021
Frequent Subgraph Mining of Functional Interaction Patterns Across Multiple CancersArda Durmaz, Tim A D Henderson, Gurkan Bebek
Pacific Symposium on Biocomputing. Pacific Symposium on Biocomputing|November 30, 2016
FREQUENT SUBGRAPH MINING OF PERSONALIZED SIGNALING PATHWAY NETWORKS GROUPS PATIENTS WITH FREQUENTLY DYSREGULATED DISEASE PATHWAYS AND PREDICTS PROGNOSISArda Durmaz, Tim A D Henderson, Douglas Brubaker, et al.
International Journal of Molecular Sciences|March 10, 2022
Personalized Risk Schemes and Machine Learning to Empower Genomic Prognostication Models in Myelodysplastic SyndromesHussein Awada, Carmelo Gurnari, Arda Durmaz, et al.
British Journal of Haematology|January 31, 2023
Are the current guidelines for identification of myelodysplastic syndrome with germline predisposition strong enough?Oriol Calvete, Julia Mestre, Arda Durmaz, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|April 16, 2026
YIA26-001: Collateral Sensitivities Emerge During the Evolution of Chemoresistance to Map Chemotherapy in OsteosarcomaZachary Burke, Gabe Mandel, Elizabeth Nowak, et al.
Blood Cells, Molecules & Diseases|February 26, 2021
Friend or foe? The case of Wilms' Tumor 1 (WT1) mutations in acute myeloid leukemiaHassan Awada, Arda Durmaz, Carmelo Gurnari, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|March 31, 2026
YIA26-001: Collateral Sensitivities Emerge During the Evolution of Chemoresistance to Map Chemotherapy in OsteosarcomaZachary Burke, Gabe Mandel, Elizabeth Nowak, et al.
NPJ Genomic Medicine|April 28, 2026
Pleiotropic germline PTEN mutations influence gastrulation through dysregulated AKT activationOmer Enes Onur, Juan Andres Venegas, Arda Durmaz, et al.
Pageof 6